Improvement of ischemic cholangiopathy in three patients with hereditary hemorrhagic telangiectasia following treatment with bevacizumab.

Vlachou, Paraskevi A; Colak, Errol; Koculym, Alexander; Kirpalani, Anish; Kim, Tae Kyoung; Hirschfield, Gideon M; Faughnan, Marie E

Vlachou, Paraskevi A; Colak, Errol; Koculym, Alexander; Kirpalani, Anish; Kim, Tae Kyoung; Hirschfield, Gideon M; Faughnan, Marie E.

Affiliation

Vlachou PA; Department of Diagnostic Imaging, St. Michael's Hospital, 30 Bond Street, Toronto, ON, Canada M5B 1W8.

J Hepatol ; 59(1): 186-9, 2013 Jul.

Article in En | MEDLINE | ID: mdl-23439260

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Bile Duct Diseases/etiology; Bile Duct Diseases/therapy; Ischemia/etiology; Ischemia/therapy; Telangiectasia, Hereditary Hemorrhagic/complications; Telangiectasia, Hereditary Hemorrhagic/therapy; Adult; Bevacizumab; Bile Ducts, Intrahepatic/blood supply; Female; Humans; Liver Transplantation; Treatment Outcome; Vascular Endothelial Growth Factor A/antagonists & inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Telangiectasia, Hereditary Hemorrhagic / Bile Duct Diseases / Antibodies, Monoclonal, Humanized / Ischemia Limits: Adult / Female / Humans Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google